drugset
drugset / Trial / NCT02796066

TSN2898-201 Safety and Efficacy of TSN2898 in the Treatment of Acne Vulgaris

NCT02796066 ↗

Phase 2 Withdrawn Thesan Pharmaceuticals, Inc.
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to determine the safety and effectiveness of TSN 2898 topical gel in the treatment of moderate to severe acne.

Timeline

Start
2016-06
Primary completion
2017-02
Completion
2017-02

Outcome

Outcome not reported

Stopped: “Protocol not approved”

Drugs

EvaluationDrugModalityDoseRoute
Subject TSN2898 Unknown — Topical

Indications

acne